HIV provider-patient communication regarding cardiovascular risk: Results from the aids treatment for life international survey

Journal of the International Association of Providers of AIDS Care

Volumn 13, Issue 4, 2014, Pages 342-345

  Sherer, Renslow ^a   Solomon, Suniti ^b   Schechter, Mauro ^c   Nachega, Jean B ^d   Rockstroh, Jurgen ^e   Zuniga, JoséM ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b Center for AIDS Research and Education (YRG CARE)   (India)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF STELLENBOSCH   (South Africa)

^e UNIVERSITY OF BONN   (Germany)

^f INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

Author keywords

Antiretroviral; Patient care; Prevention; Screening

Indexed keywords

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MALE; PATIENT EDUCATION; RISK FACTOR; YOUNG ADULT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; ASIA; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; EUROPE; FAMILY HISTORY; HEALTH SURVEY; HEART DISEASE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NORTH AMERICA; OBESITY; PREVALENCE; RISK ASSESSMENT; SELF REPORT; SMOKING; SOUTH AND CENTRAL AMERICA; TELEPHONE INTERVIEW; MEDICAL INFORMATION; PROFESSIONAL-PATIENT RELATIONSHIP;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; COMMUNICATION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS; YOUNG ADULT; ANTI-RETROVIRAL AGENTS; BODY MASS INDEX; HEALTH COMMUNICATION; HEALTH SURVEYS; HYPERTENSION; PROFESSIONAL-PATIENT RELATIONS; SMOKING;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

EID: 84905757355     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957414530473     Document Type: Article

References (15)

1. Friis-MØller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17(81179-1193.
2. Strategies for Management of Antiretroviral Therapy Study Group (SMART), El-Sadr W, Lundgren JD, et al. CD4 guided interruptions of antiretroviral treatment. N Engl J Med. 2006; 355(222283-2296.
3. Lichtenstein K, Armon C, Bucharcz K, et al. Analysis of cardiovascular risk factors in the HIV outpatient study cohort. [Abstract 755]. Presented at: 13th Conference on Retroviruses and Opportunistic Infections (CROI); February 5-8, 2006; Denver, CO.
4. Panel on the Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. March 16, 2012;1-166. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed February 27, 2012.
5. Post WS. Predicting and preventing cardiovascular disease in HIV-infected patients. Top Antivir Med. 2011;19(5169-174.
6. Thompson MA, Aberg JA, Montaner JS, et al. Antiretroviral Treatment of Adult HIV Infection: 2010 Recommendations of the International AIDS Society-USA Panel. JAMA. 2010;304(3 321-333.
7. Lumeck N, Dedes N, Pozniak A, et al. European union guidelines for the clinical management and treatment of HIV infected adults in Europe. Version 5; 2009.
8. Gazzard BG on behalf of the BHIVA Treatment Guidelines Working Group. British HIV Association Guidelines for the Treatment of HIV infected adults with Antiretroviral therapy. London: BHIVA; 2008.
9. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with the human immunodeficiency virus: 2009 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2009;49(5651-681.
10. Sherer R. The future of HIV care in the United States. Sex Transm Infect. 2012;88(2106-111.
11. Nachega JB, Morroni C, Zuniga ZM, et al. HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS treatment for life international survey. J Int Assoc Physicians AIDS Care (Chic). 2012;11(2128-133.
12. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2011;123(202292-2333.
13. Petoumenos K, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the DAD study. Presented at: 17th Conference on Retroviruses and Opportunistic Infections [Abstract 124]. San Francisco, CA; 2010.
14. Schroeder SA,Meriwether M. Smoking cessation: strategies for the HIV practitioner. IAS-USA Cases on the Web. http://www.iasusa.org/cow/cow- instructions.php?cowid=185. Accessed November 4, 2013.
15. Lo J. Dyslipidemia and lipid management in HIV-infected individuals. Curr Opin Endocrinol Diabetes Obes. 2011;18(2 144-147.